Verve Therapeutics, Inc. (VERV) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Operating Segments
05M10M15M20M25M30M35M40MQ1 2025

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
010M20M30M40M50M60M70M80MQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Operating Expenses

Research And Development ExpensesGeneral And Administrative Expenses
011M22M34M45M56M68M79M90MQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025

EBITDA

EBITDA
-70M-61M-52M-44M-35M-26M-17M-9M1Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025

EPS

Revenue Variation (%)

Revenue Variation
0255075100125150175200Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
0255075100125150175200Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Revenue YoY Variation (%)

Revenue YoY Variation
075150225300375450525600Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
075150225300375450525600Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Price-to-Earning Ratio

P/E Ratio
-7-6-5-4-3-2-101Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
02M5M8M10M12M15M18M20MQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Per Share Metrics

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
000001111Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Expense Ratios

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
02581012151820Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025
💰 Cash Flow Statement

Operating Cash Flow

Free Cash Flow

Cash At End Of Period
038M75M112M150M188M225M262M300MQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
04M8M11M15M19M22M26M30MQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025
🏦 Balance Sheet
📈 Key Metrics